(Q51006001)
Statements
1 reference
KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. (English)
1 reference
Yusuke Watanabe
1 reference
Takahiko Murata
1 reference
Masahiro Amakawa
1 reference
Yoshihide Miyake
1 reference
Tango Handa
1 reference
Katsuhiko Konishi
1 reference
Yasushi Matsumura
1 reference
Takuji Tanaka
1 reference
Koji Takeuchi
1 reference
19 February 2015
1 reference
754
1 reference
179-189
1 reference
Identifiers
1 reference